Press Releases
 
Global Silver Sulfadiazine Market Share by Industry Research 2014 - 2020

Transparency Market Research Report Added "Silver Sulfadiazine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020"

, 19 May 2017 -- Silver sulfadiazine is an antibacterial drug used for making personal care products such as anti-burn creams.The U.S. Government grants funds for the research and development of medicines to fight burn wounds, which has subsequently increased the production of Silver sulfadiazine and other similar products.

Silver sulfadiazine is an antibacterial drug used for making personal care products such as anti-burn creams. Silver sulfadiazine is listed in the World Health Organization’s List of Essential Medicines and is widely used as an antibiotic for treating second and third degree burns on the skin. Silver sulfadiazine prevents the growth of bacteria and yeast on the skin. This drug is also commonly used to treat urinary tract infections (UTIs). Sulfadiazine, when combined with pyrimethamine, is used for curing the disease Toxoplasmosis. The typical Silver sulfadiazine anti-burn lotion/creams contain 1 percent silver sulpahdiazine in it. Maintaining this concentration is really important as silver when used in excessive quantities shows toxic effects. 

Obtain Report Details @
http://www.transparencymarketresearch.com/silver-sulfadiazine-market.html

The healing capacity of silver sulfadiazine has been subject to wide speculation and numerous research studies. Cochrane, a non-profit organization, does not recommend the use of silver sulfadiazine as wounds take longer to heal when treated with medicines containing silver sulfadiazine. Despite varied market opinions; silver sulfadiazine remains to be one of the most popular medicines for treatment on burns as it’s is considered to be a powerful medication for burn wounds. Additionally, silver sulfadiazine is used in majority of the hospitals in North America as it is considered the most powerful treatment for burns. Silver sulfadiazine has been known to cause side effects such as nausea, dizziness and loss of appetite. Pregnant mothers and infants are recommended against the consumption of silver sulfadiazine in order to avoid these side effects. People having allergy to sulfa drugs are also advised not to use this medicine. These factors have limited the use of the compound in the global market.

Burn injuries have reached its epidemic proportions and are considered a healthcare problem more serious than other epidemics such as polio. According to the National Fire Protection Association (NFPA), a civilian death from fire occurs about every two hours in the U.S., which in turn have increased the demand for the wound-care products. Silver-containing wound dressings such as silver sulfadiazine has proved their effectiveness and is the most widely used medicine to cure burn injuries. Owing to this, North America has emerged as the largest consumer as well as producer for anti-burn products. The U.S. Government grants funds for the research and development of medicines to fight burn wounds, which has subsequently increased the production of Silver sulfadiazine and other similar products. The market in Asia Pacific is still relatively unexplored. 

However, countries such as China, India, Australia and Japan are expected to emerge as new players in the wound care market and are anticipated to serve as new revenue generators over the forecast period. Silver sulfadiazine is losing its edge as the major product of this industry as it has lot of undesired side effects due to which the effectiveness of Silver sulfadiazine is still being debated upon. Furthermore, the rising price of Silver, which is one of the prime raw materials for the production of silver sulfadiazine, is a matter of concern. In addition, for improving synthetic dressing materials, advanced technologies in wound treatment which include the xenogeneic tissue scaffold, endovascular arterial repair techniques, endoscopic subfascial ligation of venous perforators, recombinant growth factors, bilayered human dermal substitutes, and hyperbaric oxygen therapy is forcing silver sulfadiazine to lose its market importance.

Johnson & Johnson Limited, 3M Company, Baxter International Inc Monarch Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. are some of the key players in this market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3956

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

# # #


Submitted by Sandy Researcher, Transparency Market Research on Friday, 19 May 2017 at 6:48 PM
Category: Health Care & Medical
 
Related News

Global Health IT Security Industry Analysis, Size, Forecast to 2023
Wednesday, 23 Aug 2017

Global Bioengineered Protein Drugs Market is expected to become worth US$336.9 bn by 2025
Tuesday, 22 Aug 2017

Cancer Biomarkers Market will explore robust size & growth during 2017-2025
Tuesday, 22 Aug 2017

Alpha 1 Antitrypsin Deficiency Treatment Market: Current Market and Future Players
Tuesday, 22 Aug 2017

New Trends of Microbiology Culture Market with Worldwide Industry Analysis to 2023
Tuesday, 22 Aug 2017

Related Events

Physician Assistant Board Review - A comprehensive review for PAs and NPs
Tuesday, 22 Aug 2017

Measuring Health Outcomes Melbourne August 2017
Tuesday, 22 Aug 2017

Hospital Management Asia 2017
Wednesday, 23 Aug 2017

Cardiovascular Review Course for Cardiology Boards and Recertification
Sunday, 27 Aug 2017

WATOC 2017 - World Association of Theoretical and Computational Chemists
Sunday, 27 Aug 2017

Latest News

Best-Movers.com Simplifies Moving Process
Wednesday, 23 Aug 2017

correct steps for vertical roller mill operation
Wednesday, 23 Aug 2017

Placide Joliet Offers Customers Easier Moving Solutions
Wednesday, 23 Aug 2017

BTS7-7% off code for you to buy Runescape 2007 Gold and enjoy Fossil Island 8.24-8.31
Wednesday, 23 Aug 2017

Time to gain Back-to-School present:7% off RS3 Gold for Shattered Worlds 8.24-8.31
Wednesday, 23 Aug 2017

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2017
Today is Wednesday, 23 August 2017

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 17th Internatio\
  • NEW YORK FINTECH WEEK 2017
  • Physician Assistant Board Review - A comprehensive review for PAs and NPs
  • Measuring Health Outcomes Melbourne August 2017
  • Driving Growth in Disability Housing Sydney August 2017

  • Latest Jobs
  • Gold Ore Milling Machine Advantages
  • London Investment Property
  • We Are Hiring A Content Manager!